{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:49:44Z","timestamp":1792658984770,"version":"4.5.0"},"reference-count":57,"publisher":"American Society for Clinical Investigation","issue":"18","license":[{"start":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T00:00:00Z","timestamp":1600300800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"crossref","award":["MOP-142221,PJT-153095"],"award-info":[{"award-number":["MOP-142221,PJT-153095"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes & Digestive & Kidney Diseases","doi-asserted-by":"crossref","award":["5R01DK075302"],"award-info":[{"award-number":["5R01DK075302"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,9,17]]},"abstract":"<jats:p>\n                    Based on its clinical benefits, Trikafta \u2014 the combination of folding correctors VX-661 (tezacaftor), VX-445 (elexacaftor), and the gating potentiator VX-770 (ivacaftor) \u2014 was FDA approved for treatment of patients with cystic fibrosis (CF) carrying deletion of phenylalanine at position 508 (F508del) of the CF transmembrane conductance regulator (\n                    <jats:italic>CFTR<\/jats:italic>\n                    ) on at least 1 allele. Neither the mechanism of action of VX-445 nor the susceptibility of rare CF folding mutants to Trikafta are known. Here, we show that, in human bronchial epithelial cells, VX-445 synergistically restores F508del-CFTR processing in combination with type I or II correctors that target the nucleotide binding domain 1 (NBD1) membrane spanning domains (MSDs) interface and NBD2, respectively, consistent with a type III corrector mechanism. This inference was supported by the VX-445 binding to and unfolding suppression of the isolated F508del-NBD1 of CFTR. The VX-661 plus VX-445 treatment restored F508del-CFTR chloride channel function in the presence of VX-770 to approximately 62% of WT CFTR in homozygous nasal epithelia. Substantial rescue of rare misprocessing mutations (S13F, R31C, G85E, E92K, V520F, M1101K, and N1303K), confined to MSD1, MSD2, NBD1, and NBD2 of CFTR, was also observed in airway epithelia, suggesting an allosteric correction mechanism and the possible application of Trikafta for patients with rare misfolding mutants of CFTR.\n                  <\/jats:p>","DOI":"10.1172\/jci.insight.139983","type":"journal-article","created":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T12:01:16Z","timestamp":1598529676000},"source":"Crossref","is-referenced-by-count":257,"title":["Allosteric folding correction of F508del and rare CFTR mutants by elexacaftor-tezacaftor-ivacaftor (Trikafta) combination"],"prefix":"10.1172","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6758-2696","authenticated-orcid":true,"given":"Guido","family":"Veit","sequence":"first","affiliation":[{"name":"Department of Physiology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel","family":"Roldan","sequence":"additional","affiliation":[{"name":"Department of Physiology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7427-7449","authenticated-orcid":true,"given":"Mark A.","family":"Hancock","sequence":"additional","affiliation":[{"name":"SPR-MS Facility, McGill University, Montr\u00e9al, Quebec, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dillon F.","family":"Da Fonte","sequence":"additional","affiliation":[{"name":"Department of Physiology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haijin","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Physiology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5922-7312","authenticated-orcid":true,"given":"Maytham","family":"Hussein","sequence":"additional","affiliation":[{"name":"Department of Pharmacology & Therapeutics, School of Biomedical Sciences, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Melbourne, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saul","family":"Frenkiel","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology-Head and Neck Surgery,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Matouk","sequence":"additional","affiliation":[{"name":"Adult Cystic Fibrosis Clinic, Montreal Chest Institute, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0017-7952","authenticated-orcid":true,"given":"Tony","family":"Velkov","sequence":"additional","affiliation":[{"name":"Department of Pharmacology & Therapeutics, School of Biomedical Sciences, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Melbourne, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0900-0675","authenticated-orcid":true,"given":"Gergely L.","family":"Lukacs","sequence":"additional","affiliation":[{"name":"Department of Physiology and"},{"name":"Department of Biochemistry, McGill University, Montr\u00e9al, Quebec, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"232","published-online":{"date-parts":[[2020,9,17]]},"reference":[{"issue":"1","key":"B1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrg3849","article-title":"Cystic fibrosis genetics: from molecular understanding to clinical application","volume":"16","author":"Cutting","year":"2015","journal-title":"Nat Rev Genet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2745"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)90353-R"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra043184"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.e14-04-0935"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.02.024"},{"key":"B7","article-title":"CFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine","volume":"10","author":"Lopes-Pacheco","year":"2019","journal-title":"Front Pharmacol"},{"key":"B8","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/j.jcf.2019.10.017","article-title":"CFTR processing, trafficking and interactions","volume":"19 Suppl 1","author":"Amaral","year":"2020","journal-title":"J Cyst Fibros"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2011.10.003"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/nsmb882"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.e08-09-0950"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/354526a0"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1126\/science.1191542"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.biochem.75.103004.142532"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32597-8"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1908639"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1807120"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.11.024"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.1253"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.11.023"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0200-x"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s00441-005-0062-7"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/prot.25496"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.e13-05-0240"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2019.04.014"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.119.261800"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2007.11.012"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1124\/mol.117.108373"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.41.25421"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/18.6.1492"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/pro.480"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M309076200"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddx367"},{"key":"B34","doi-asserted-by":"crossref","unstructured":"Guimbellot JS, et al. Variable cellular ivacaftor concentrations in people with cystic fibrosis on modulator therapy [published ahead of print February 7, 2020]. J Cyst Fibros. https:\/\/doi.org\/10.1016\/j.jcf.2020.01.011","DOI":"10.1016\/j.jcf.2020.01.011"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3008889"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3008680"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2013.06.008"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-07504-1"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201808-1436LE"},{"issue":"13","key":"B40","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.99385","article-title":"Brushed nasal epithelial cells are a surrogate for bronchial epithelial CFTR studies","volume":"3","author":"Brewington","year":"2018","journal-title":"JCI Insight"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1105185"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201802-149OC"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201503-0578OC"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu944"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.06697"},{"key":"B46","doi-asserted-by":"crossref","unstructured":"Dukovski D, et al. Amplifiers co-translationally enhance CFTR biosynthesis via PCBP1-mediated regulation of CFTR mRNA [published ahead of print February 16, 2020]. J Cyst Fibros. https:\/\/doi.org\/10.1016\/j.jcf.2020.02.006","DOI":"10.1016\/j.jcf.2020.02.006"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-54158-2"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2019.10.011"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01661-2015"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1124\/mol.115.099689"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2006.10.086"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.e12-06-0424"},{"issue":"80","key":"B53","article-title":"Culturing of human nasal epithelial cells at the air liquid interface","year":"2013","journal-title":"J Vis Exp"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2011.10.036"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-1352(199909\/10)12:5<279::AID-JMR473>3.0.CO;2-3"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.12.6643"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-010-0297-1"}],"container-title":["JCI Insight"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/insight.jci.org\/articles\/view\/139983\/files\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:53:40Z","timestamp":1779152020000},"score":1,"resource":{"primary":{"URL":"https:\/\/insight.jci.org\/articles\/view\/139983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,17]]},"references-count":57,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2020,9,17]]},"published-print":{"date-parts":[[2020,9,17]]}},"alternative-id":["10.1172\/jci.insight.139983"],"URL":"https:\/\/doi.org\/10.1172\/jci.insight.139983","relation":{},"ISSN":["2379-3708"],"issn-type":[{"value":"2379-3708","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,17]]},"article-number":"e139983"}}